Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody

被引:2
|
作者
Lin, Yu-Wei [1 ]
Su, Hung-Cheng [1 ]
Raj, Emmanuel Naveen [2 ]
Liu, Kuang-Kai [1 ]
Chang, Chien-Jen [1 ,3 ]
Hsu, Tzu-Chia [1 ]
Cheng, Po-Yun [1 ]
Wang, Rou-Hsin [1 ,2 ]
Lai, Yen-Her [2 ]
Chen, Chien-Hung [1 ]
Lin, Yen-Cheng [1 ]
Chao, Jui-, I [1 ,2 ,4 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30068, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu 30068, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu 30068, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices, Hsinchu 30068, Taiwan
关键词
nanodiamond; cetuximab; lung cancer therapy; EGFR; tumorigenesis; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; FLUORESCENT NANODIAMOND; MONOCLONAL-ANTIBODY; ACQUIRED-RESISTANCE; DRUG-DELIVERY; NANOPARTICLES; MUTATIONS; CETUXIMAB; TRACKING;
D O I
10.3390/pharmaceutics15010111
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoprobes provide advantages for real-time monitoring of tumor markers and tumorigenesis during cancer progression and development. Epidermal growth factor receptor (EGFR) is a key protein that plays crucial roles for tumorigenesis and cancer therapy of lung cancers. Here, we show a carbon-based nanoprobe, nanodiamond (ND), which can be applied for targeting EGFR and monitoring tumorigenesis of human lung cancer cells in vitro and in vivo. The optimal fluorescent intensities of ND particles were observed in the human lung cancer cells and nude mice under in vivo imaging system. The fluorescence signal of ND particles can be real-time detected in the xenografted human lung tumor formation of nude mice. Moreover, the ND-conjugated specific EGFR antibody cetuximab (Cet) can track the location and distribution of EGFR proteins of lung cancer cells in vitro and in vivo. ND-Cet treatment increased cellular uptake ability of nanocomposites in the EGFR-expressed cells but not in the EGFR-negative lung cancer cells. Interestingly, single ND-Cet complex can be directly observed on the protein G bead by immunoprecipitation and confocal microscopy. Besides, the EGFR proteins were transported to lysosomes for degradation. Together, this study demonstrates that ND-conjugated Cet can apply for targeting EGFR and monitoring tumorigenesis during lung cancer progression and therapy.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] In Vitro and in Vivo Efficacy of AZD9291 Is Enhanced by Combination with AZD4547 in EGFR Mutant Lung Cancer Cells
    Chan, Daniel C.
    Hinz, Trista K.
    Marek, Lindsay A.
    Zhang, Zhiyong
    Nguyen, Teresa T.
    Bunn, Paul A., Jr.
    Heasley, Lynn
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S580 - S581
  • [32] EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
    Chang, Hyun
    Oh, Jisu
    Zhang, Xianglan
    Kim, Yu Jung
    Lee, Jae Ho
    Lee, Choon-Taek
    Chung, Jin-haeng
    Lee, Jong-Seok
    ONCOTARGETS AND THERAPY, 2016, 9 : 5153 - 5162
  • [33] Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo
    Xishan Xiong
    Lili Fu
    Li Wang
    Houan Cai
    Lin Li
    Hualiang Jiang
    Wenhu Duan
    Changlin Mei
    Investigational New Drugs, 2009, 27
  • [34] Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo
    Xiong, Xishan
    Fu, Lili
    Wang, Li
    Cai, Houan
    Li, Lin
    Jiang, Hualiang
    Duan, Wenhu
    Mei, Changlin
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (01) : 1 - 11
  • [35] Dual effects of a CpG-DNAzyme targeting mutant EGFR transcripts in lung cancer cells: TLR9 activation and EGFR downregulation
    Jang, Dahye
    Baek, Yu Mi
    Park, Hanna
    Hwang, Yeo Eun
    Kim, Dong-Eun
    BMB REPORTS, 2018, 51 (01) : 27 - 32
  • [36] Microrna-144 Expression Overcomes Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells by Targeting Survivin
    Hwang, Ki Eun
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    CHEST, 2016, 150 (04) : 714A - 714A
  • [37] LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation
    Wu, Ying
    Yu, Dan-dan
    Hu, Yong
    Cao, Hai-xia
    Yu, Shao-rong
    Liu, Si-wen
    Feng, Ji-feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 900 - 905
  • [38] Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo
    Wu, Shuifa
    Deng, Cuimin
    Zhang, Caiyun
    Xiong, Jiani
    Gu, Xiaofan
    Wang, Ze
    Tu, Jingjing
    Xie, Jieming
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (08): : 1549 - 1560
  • [39] Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo
    Shuifa Wu
    Cuimin Deng
    Caiyun Zhang
    Jiani Xiong
    Xiaofan Gu
    Ze Wang
    Jingjing Tu
    Jieming Xie
    Clinical and Translational Oncology, 2021, 23 : 1549 - 1560
  • [40] Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer
    Kitamura, Atsuko
    Hosoda, Waki
    Sasaki, Eiichi
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    CLINICAL CANCER RESEARCH, 2010, 16 (13) : 3349 - 3355